Institutional Ownership Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX). We have compiled data on the 71 institutions that hold shares in the stock, with a total of 46.2 Million shares, which have been reported (via 13F filing form) to have a value of $28.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
7,311,760
shares
|
$4.46 Million
0.57% of portfolio
|
Q4 2024
Reduced 6.4%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
5,228,461
shares
|
$3.19 Million
0.2% of portfolio
|
Q2 2024
Reduced 20.73%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
5,162,302
shares
|
$3.15 Million
0.0% of portfolio
|
Q3 2024
Added 5.52%
|
|
|
Prosight Management, LP
Dallas, TX |
Feb 14, 2025 Q4 2024 |
3,905,000
shares
|
$2.38 Million
1.19% of portfolio
|
Q4 2024
Added 29.21%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
3,221,012
shares
|
$1.96 Million
0.0% of portfolio
|
Q4 2024
Added 25.81%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Feb 11, 2025 Q4 2024 |
3,137,046
shares
|
$1.91 Million
0.01% of portfolio
|
Q4 2024
Added 1.16%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
2,650,000
shares
|
$1.62 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
1,547,215
shares
|
$943,801
0.01% of portfolio
|
Q4 2024
Added 1.52%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
1,380,800
shares
|
$842,288
0.01% of portfolio
|
Q4 2024
Added 13.95%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,346,800
shares
|
$821,548
0.0% of portfolio
|
Q4 2024
Added 32.69%
|
|
|
Laurion Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
1,248,364
shares
|
$761,502
0.02% of portfolio
|
Q3 2024
Reduced 18.21%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,139,029
shares
|
$694,807
0.0% of portfolio
|
Q2 2024
Added 0.69%
|
|
|
Congress Park Capital LLC
|
Jan 14, 2025 Q4 2024 |
964,590
shares
|
$588,399
0.37% of portfolio
|
Q4 2024
Reduced 20.68%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
815,643
shares
|
$497,542
0.0% of portfolio
|
Q4 2024
Added 1.51%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
811,630
shares
|
$495,094
0.0% of portfolio
|
Q4 2024
Added 288736.31%
|
|
|
Assenagon Asset Management S.A.
|
Apr 15, 2025 Q1 2025 |
711,454
shares
|
$433,986
0.0% of portfolio
|
Q1 2025
Added 18.61%
|
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
508,556
shares
|
$310,219
0.0% of portfolio
|
Q4 2024
Added 635.6%
|
|
|
Sei Investments CO
Oaks, PA |
Feb 11, 2025 Q4 2024 |
487,902
shares
|
$297,620
0.0% of portfolio
|
Q3 2024
Added 27.48%
|
|
|
Altium Capital Management LP
New York, NY |
Feb 13, 2025 Q4 2024 |
467,491
shares
|
$285,169
0.16% of portfolio
|
Q4 2024
Reduced 48.91%
|
|
|
Toroso Investments, LLC
Massapequa, NY |
Feb 14, 2025 Q4 2024 |
382,529
shares
|
$233,342
0.0% of portfolio
|
Q4 2024
Added 55.5%
|
|
|
Formidable Asset Management, LLC
Cincinnati, OH |
Feb 19, 2025 Q4 2024 |
382,529
shares
|
$233,342
0.07% of portfolio
|
Q4 2024
Added 55.5%
|
|
|
Monimus Capital Management, LP
Woodbridge, NJ |
Feb 10, 2025 Q4 2024 |
364,306
shares
|
$222,226
0.35% of portfolio
|
Q4 2024
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
331,624
shares
|
$202,290
0.01% of portfolio
|
Q4 2024
Reduced 7.01%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
322,311
shares
|
$196,609
0.0% of portfolio
|
Q4 2024
Added 1.64%
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
320,767
shares
|
$195,667
0.0% of portfolio
|
Q4 2024
Reduced 31.96%
|